Developing AI tools to predict how T cells recognize cancer antigens
MATCHMAKERS - Creating and training AI tools for TCR binding prediction and design
This study is exploring how our immune system's T cells recognize cancer markers, using smart computer techniques to help develop better treatments that specifically target tumors.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-11045160 on NIH RePORTER |
What this research studies
This research focuses on understanding how T cell receptors (TCRs) identify tumor antigens presented by major histocompatibility complexes (MHCs). By combining advanced machine learning techniques with extensive data on TCR-pMHC pairs, the project aims to create accurate predictive models for TCR-antigen recognition. The research involves generating large datasets from both human and mouse sources and utilizing synthetic approaches to enhance TCR matching. This could lead to improved antigen-specific immunotherapies for cancer treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with malignant neoplasms who may benefit from targeted immunotherapy.
Not a fit: Patients with non-malignant conditions or those not eligible for immunotherapy may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized cancer immunotherapies.
How similar studies have performed: Other research has shown promise in using machine learning for predicting TCR interactions, indicating a potential for success in this novel approach.
Where this research is happening
Cambridge, United States
- Massachusetts Institute of Technology — Cambridge, United States (Active)
Researchers
- Principal investigator: Birnbaum, Michael — Massachusetts Institute of Technology
- Study coordinator: Birnbaum, Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.